The biogenic trace amine tyramine induces a pronounced hydroxyl radical production via a monoamine oxidase dependent mechanism: An in vivo microdialysis study in mouse striatum

Brain Research

Volumn 1012, Issue 1-2, 2004, Pages 101-107

  Schmidt, Nicole ^a   Ferger, Boris ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Catecholamines monoamines; Hydroxyl radical; Microdialysis; Monoamine oxidase; Neuroprotection; Neurotransmitters, modulators, transporters and receptors; Tyramine

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMINE OXIDASE (FLAVIN CONTAINING); BIOGENIC AMINE; DOPAMINE; HYDROXYL RADICAL; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; SALICYLIC ACID; TRANYLCYPROMINE; TYRAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; DIALYSATE; DOPAMINERGIC SYSTEM; EXTRACELLULAR SPACE; HYDROXYLATION; IN VIVO STUDY; INJECTION; LIQUID; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; FREE RADICALS; HYDROXYL RADICAL; MALE; MICE; MICRODIALYSIS; MONOAMINE OXIDASE; NEOSTRIATUM; TRANYLCYPROMINE; TYRAMINE;

EID: 2442599894     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.03.036     Document Type: Article

References (35)

1. Abercrombie E.D., Bonatz A.E., Zigmond M.J. Effects of L-dopa on extracellular dopamine in the striatum of normal and 6-hydroxydopamine-treated rats. Brain Res. 525:1990;36-44
2. Arenas J., Campos Y., Ribacoba R., Martin M.A., Rubio J.C., Ablanedo P., Cabello A. Complex I defect in muscle from patients with Huntington's disease. Ann. Neurol. 43:1998;397-400
3. Burke W.J. 3, 4-Dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinson's disease. Curr. Drug Target CNS Neurol. Disord. 2:2003;143-148
4. Cassarino D.S., Bennett J.P. Jr. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res. Brain Res. Rev. 29:1999;1-25
5. Celada P., Artigas F. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat, Naunyn Schmiedeberg's. Arch. Pharmacol. 347:1993;583-590
6. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:1979;527-605
7. Cohen G., Kesler N. Monoamine oxidase and mitochondrial respiration. J. Neurochem. 73:1999;2310-2315
8. Cohen G., Farooqui R., Kesler N. Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4890-4894
9. Fairbrother I.S., Arbuthnott G.W., Kelly J.S., Butcher S.P. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine. J. Neurochem. 6:1990;1844-1851
10. Fornai F., Chen K., Giorgi F.S., Gesi M., Alessandri M.G., Shih J.C. Striatal dopamine metabolism in monoamine oxidase B-deficient mice: a brain dialysis study. J. Neurochem. 73:1999;2434-2440
11. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, New York
12. Giulivi C., Cadenas E. The role of mitochondrial glutathione in DNA base oxidation. Biochim. Biophys. Acta. 1366:1998;265-274
13. 2 and hydroxyl radicals but not glutathione-protein-mixed disulfides. J. Neurochem. 82:2002;66-74
14. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623
15. Halliwell B., Kaur H., Ingelmann-Sundberg M. Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. Free Radic. Biol. Med. 10:1991;439-441
16. Hauptmann N., Grimsby J., Shih J.C., Cadenas E. The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA. Arch. Biochem. Biophys. 335:1996;295-304
17. Juorio A.V., Boulton A.A. The effect of some precursor amino acids and enzyme inhibitors on the mouse striatal concentration of tyramines and homovanillic acid. J. Neurochem. 39:1982;859-863
18. Li S.W., Lin T.S., Minteer S., Burke W.J. 3, 4- Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis. Brain Res. Mol. Brain Res. 93:2001;1-7
19. Marcocci L., de Marchi U., Salvi M., Milella Z.G., Nocera S., Agostinelli E., Mondovi B., Toninello A. Tyramine and monoamine oxidase inhibitors as modulators of the mitochondrial membrane permeability transition. J. Membr. Biol. 188:2002;23-31
20. Maurel A., Hernandez C., Kunduzova O., Bompart G., Cambon C., Parini A., Frances B. Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats. Am. J. Physiol, Heart Circ. Physiol. 284:2003;H1460-H1467
21. Nestler E.J., Hyman S.E., Malenka R.C. Catecholamines. Nestler E.J., Hyman S.E., Malenka R.C. Molecular Neuropharmacology: a Foundation for Clinical Neuroscience. 2001;167-190 McGraw-Hill, New York
22. Nguyen T.V., Juorio A.V. Binding sites for brain trace amines. Cell. Mol. Neurobiol. 9:1989;297-311
23. Obata T., Yamanaka Y. Prazosine attenuates hydroxyl radical generation in the rat myocardium. Eur. J. Pharmacol. 379:1999;161-166
24. Sardar A., Juorio A.V., Boulton A.A. The concentration of p- and m-tyramine in the rat mesolimbic system: its regional distribution and effect of monoamine oxidase inhibition. Brain Res. 412:1987;370-374
25. Schapira A.H. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia. Biochim. Biophys. Acta. 1410:1999;159-170
26. Schmidt N., Ferger B. Neuroprotective effects of (±)-kavain in the MPTP mouse model of Parkinson's disease. Synapse. 40:2001;47-54
27. Schmidt N., Ferger B. Neurochemical findings in the MPTP model of Parkinson's disease. J. Neural Transm. 108:2001;1263-1282
28. Singer T.P., Salach J.I., Crabtree D. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Biochem. Biophys. Res. Commun. 127:1985;707-712
29. Singer T.P., Salach J.I., Castagnoli N. Jr., Trevor A. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine with monoamine oxidases. Biochem. J. 235:1986;785-789
30. Sohal R.S., Sohal B.H., Orr W.C. Mitochondrial superoxide and hydrogen peroxide generation, protein oxidative damage, and longevity in different species of flies. Free Radic. Biol. Med. 19:1995;499-504
31. Themann C., Teismann P., Kuschinsky K., Ferger B. Comparison of two independent aromatic hydroxylation assays in combination with intracerebral microdialysis to determine hydroxyl free radicals. J. Neurosci. Methods. 108:2001;57-64
32. Vaccari A., Saba P. The tyramine-labelled vesicular transporter for dopamine: a putative target of pesticides and neurotoxins. Eur. J. Pharmacol. 292:1995;309-314
33. Wei Q., Yeung M., Juma O.P., Andersen J.K. Genetic elevation of monoamine oxidase levels in dopaminergic PC12 cells results in increased free radical damage and sensitivity to MPTP. J. Neurosci. Res. 46:1996;666-673
34. Zetterström T., Sharp T., Collin A.K., Ungerstedt U. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148:1988;327-334
35. Zigmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., Stricker E.M. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci. 17:1990;290-296